[26] |
李增军,王海鹏,宋宝, 等. 高迁移率族蛋白1在结肠癌组织中的表达及临床意义 [J]. 中华胃肠外科杂志, 2015, 18(6): 616-619.
|
[1] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018, 68: 394-424.
|
[2] |
Yang CA, Huang HY, Chang YS, et al. DNA-sensing and nuclease gene expressions as markers for colorectal cancer progression [J]. Oncology, 2017, 92(2): 115-124.
|
[3] |
Ekanayaka SA, McClellan SA, Peng X, et al. HMGB1 antagonist, box A, reduces TLR4, RAGE, and inflammatory cytokines in the cornea of P. aeruginosa-infected mice [J]. J Ocul Pharmacol Ther, 2018, 34(10): 659-669.
|
[4] |
Schade GR, Wang YN, D'Andrea S, et al. Boiling histotripsy ablation of renal cell carcinoma in the eker rat promotes a systemic inflammatory response [J]. Ultrasound Med Biol, 2018, 45(1): 137-147.
|
[5] |
Li S, Gu H, Huang Y, et al. Circular RNA 101368/miR-200a axis modulates the migration of hepatocellular carcinoma through HMGB1/RAGE signaling [J]. Cell Cycle, 2018, 17(19-20): 2349-2359.
|
[6] |
Wang L, Kang FB, Wang J, et al. Downregulation of miR-205 contributes to epithelial-mesenchymal transition and invasion in triple-negative breast cancer by targeting HMGB1-RAGE signaling pathway [J]. Anticancer Drugs, 2019, 30(3): 225-232.
|
[7] |
Liu Y, Du M, Song Y, et al. NAC1/HMGB1 signaling pathway is associated with epithelial-mesenchymal transition, invasion, and metastasis of lung cancer cell line [J]. Ann Clin Lab Sci, 2018, 48(5): 559-564.
|
[8] |
Sun E, Liu K, Zhao K, et al. Serine/threonine kinase 32C is overexpressed in bladder cancer and contributes to tumor progression [J]. Cancer Biol Ther, 2019, 20(3): 307-320.
|
[9] |
Williams HL, Walsh K, Diamond A, et al. Validation of the oncomine focus panel for next-generation sequencing of clinical tumour samples [J]. Virchows Arch, 2018, 473(4): 489-503.
|
[10] |
Notterman DA, Alon U, Sierk AJ, et al. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays [J]. Cancer Res, 2001, 61(7): 3124-3130.
|
[11] |
Sabates-Bellver J, Van der Flier LG, de Palo M, et al. Transcriptome profile of human colorectal adenomas [J]. Mol Cancer Res, 2007, 5(12): 1263-1275.
|
[12] |
Skrzypczak M, Goryca K, Rubel T, et al. Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability [J]. PLoS One, 2010, 5(10): e13091.
|
[13] |
Alon U, Barkai N, Notterman DA, et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays [J]. Proc Natl Acad Sci USA, 1999, 96(12): 6745-6750.
|
[14] |
Gaedcke J, Grade M, Jung K, et al. Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas [J]. Genes Chromosomes Cancer, 2010, 49(11): 1024-1034.
|
[15] |
Hong Y, Downey T, Eu KW, et al. A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics [J]. Clin Exp Metastasis, 2010, 27(2): 83-90.
|
[16] |
Kaiser S, Park YK, Franklin JL, et al. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer [J]. Genome Biol, 2007,8(7): R131.
|
[17] |
Ki DH, Jeung HC, Park CH, et al. Whole genome analysis for liver metastasis gene signatures in colorectal cancer [J]. Int J Cancer, 2007, 121(9): 2005-2012.
|
[18] |
Kurashina K, Yamashita Y, Ueno T, et al. Chromosome copy number analysis in screening for prognosis-related genomic regions in colorectal carcinoma [J]. Cancer Sci, 2008, 99(9): 1835-1840.
|
[19] |
Notterman DA, Alon U, Sierk AJ, et al. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays [J]. Cancer Res, 2001, 61(7): 3124-3130.
|
[20] |
Yang H, Wang H, Chavan SS, et al. High mobility group box protein 1 (HMGB1): The prototypical endogenous danger molecule [J]. Mol Med, 2015, 21 (Suppl 1): S6-S12.
|
[21] |
徐荣辉,穆向明. 左半结肠癌与右半结肠癌差异性研究进展 [J/CD]. 心血管外科杂志(电子版), 2019, 8(1): 194-195.
|
[22] |
Taguchi A, Blood DC, del Toro G, et al.Blockade od RAGE-amphoterin signalingsuppresses tumour growth and metastasis [J]. Nature, 2000, 405(6784): 354-360.
|
[23] |
Sasahira T, Kirita T, Oue N, et al. HMGB1-inducible melanoma inhibitoryactivity is associated with nodal metastasisand lymphangiogenesis in oral squamouscell carcinoma [J]. Cancer Sci, 2008, 99 (9) :1806-1812.
|
[24] |
Treutiger CJ, Mullins GE, Johansson AS, et al.High mobility groop1B-boxmediates activation of human endothelium [J]. J Intern Med, 2003, 254(4): 375-385.
|
[25] |
闻莲,何雪晴,钱一可, 等. HMGB1在抗肿瘤免疫发生中的作用[J].生命的化学, 2020, 40(4): 483-489.
|